{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:49:25Z","timestamp":1773413365884,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04710-1","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T04:20:15Z","timestamp":1770610815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A rare presentation of pediatric MOG-antibody-associated neuroretinitis: a case report"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-7112","authenticated-orcid":false,"given":"Ayfer","family":"Ardu\u00e7-Ak\u00e7ay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6816-5081","authenticated-orcid":false,"given":"Yusuf H\u00fcseyin","family":"Berrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1716-5488","authenticated-orcid":false,"given":"Ay\u015fe","family":"Y\u0131ld\u0131z-Ta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"1","key":"4710_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e31820cf78a","volume":"31","author":"V Purvin","year":"2011","unstructured":"Purvin V, Sundaram S, Kawasaki A. Neuroretinitis: review of the literature and new observations. J Neuroophthalmol. 2011;31(1):58\u201368. https:\/\/doi.org\/10.1097\/WNO.0b013e31820cf78a.","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"4710_CR2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/ICU.0000000000000527","volume":"29","author":"A Abdelhakim","year":"2018","unstructured":"Abdelhakim A, Rasool N. Neuroretinitis: A review. Curr Opin Ophthalmol. 2018;29(6):514\u20139. https:\/\/doi.org\/10.1097\/ICU.0000000000000527.","journal-title":"Curr Opin Ophthalmol"},{"key":"4710_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41433-024-03466-7","volume":"39","author":"J Shi","year":"2025","unstructured":"Shi J, Danesh-Meyer HV, Bhatti MT. Neuroretinitis: A comprehensive review on aetiologies, clinical manifestations, and treatment options. Eye. 2025;39:238\u201350. https:\/\/doi.org\/10.1038\/s41433-024-03466-7.","journal-title":"Eye"},{"issue":"2","key":"4710_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/0972-2327.41879","volume":"11","author":"SK Narayan","year":"2008","unstructured":"Narayan SK, Kaliaperumal S, Srinivasan R. Neuroretinitis: A great mimicker. Ann Indian Acad Neurol. 2008;11(2):109\u201313. https:\/\/doi.org\/10.4103\/0972-2327.41879.","journal-title":"Ann Indian Acad Neurol"},{"issue":"11","key":"4710_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/bjophthalmol-2020-317267","volume":"105","author":"AR Vosoughi","year":"2021","unstructured":"Vosoughi AR, Ling J, Tam KT, Blackwood J, Micieli JA. Ophthalmic manifestations of Myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: A systematic review. Br J Ophthalmol. 2021;105(11):1591\u20138. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317267.","journal-title":"Br J Ophthalmol"},{"key":"4710_CR6","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1038\/s41433-023-02477-0","volume":"37","author":"N Moheb","year":"2023","unstructured":"Moheb N, Chen JJ. The neuro-ophthalmological manifestations of NMOSD and MOGAD: A comprehensive review. NMOSD MOGAD:Eye. 2023;37:2391\u20138. https:\/\/doi.org\/10.1038\/s41433-023-02477-0.","journal-title":"NMOSD MOGAD:Eye"},{"key":"4710_CR7","doi-asserted-by":"publisher","first-page":"1260358","DOI":"10.3389\/fneur.2023.1260358","volume":"14","author":"JY Hor","year":"2023","unstructured":"Hor JY, Fujihara K. Epidemiology of Myelin oligodendrocyte glycoprotein antibody-associated disease: A review of prevalence and incidence worldwide. Front Neurol. 2023;14:1260358. https:\/\/doi.org\/10.3389\/fneur.2023.1260358.","journal-title":"Front Neurol"},{"key":"4710_CR8","doi-asserted-by":"publisher","unstructured":"Choi J, Bossuyt A, Chan NSW, Wu G. (2022). Paediatric retinal inflammatory disorders. In R. V. P. Chan, editor, Pediatric retinal diseases (Retina Atlas, pp. 1\u201320). Springer. https:\/\/doi.org\/10.1007\/978-981-19-1364-8_9","DOI":"10.1007\/978-981-19-1364-8_9"},{"issue":"1","key":"4710_CR9","doi-asserted-by":"publisher","first-page":"e200065","DOI":"10.1212\/NXI.0000000000200065","volume":"10","author":"M Nosadini","year":"2022","unstructured":"Nosadini M, Eyre M, Giacomini T, et al. Early immunotherapy and longer corticosteroid treatment are associated with lower risk of relapsing disease course in pediatric MOGAD. Neurology: Neuroimmunol Neuroinflammation. 2022;10(1):e200065. https:\/\/doi.org\/10.1212\/NXI.0000000000200065.","journal-title":"Neurology: Neuroimmunol Neuroinflammation"},{"issue":"2","key":"4710_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/DLJO.DLJO_97_24","volume":"35","author":"SG Parab","year":"2025","unstructured":"Parab SG, Sahdev SI. Spectrum of optic disc edema with macular star and neuroretinitis: A literature review. Delhi J Ophthalmol. 2025;35(2):85\u201391. https:\/\/doi.org\/10.4103\/DLJO.DLJO_97_24.","journal-title":"Delhi J Ophthalmol"},{"key":"4710_CR11","doi-asserted-by":"publisher","first-page":"885218","DOI":"10.3389\/fneur.2022.885218","volume":"13","author":"E Sechi","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022;13:885218. https:\/\/doi.org\/10.3389\/fneur.2022.885218.","journal-title":"Front Neurol"},{"issue":"5","key":"4710_CR12","doi-asserted-by":"publisher","first-page":"e200275","DOI":"10.1212\/NXI.0000000000200275","volume":"11","author":"CE Moseley","year":"2024","unstructured":"Moseley CE, Virupakshaiah A, Forsthuber TG, Steinman L, Waubant E, Zamvil SS. MOG CNS autoimmunity and MOGAD. Neurol: Neuroimmunol Neuroinflamma. 2024;11(5):e200275. https:\/\/doi.org\/10.1212\/NXI.0000000000200275.","journal-title":"Neurol: Neuroimmunol Neuroinflamma"},{"key":"4710_CR13","doi-asserted-by":"publisher","first-page":"1209749","DOI":"10.3389\/fneur.2023.1209749","volume":"14","author":"Y Takai","year":"2023","unstructured":"Takai Y, Misu T, Fujihara K, Aoki M. Pathology of Myelin oligodendrocyte glycoprotein antibody-associated disease: A comparison with multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis Optica spectrum disorders. Front Neurol. 2023;14:1209749. https:\/\/doi.org\/10.3389\/fneur.2023.1209749.","journal-title":"Front Neurol"},{"key":"4710_CR14","doi-asserted-by":"publisher","first-page":"1137998","DOI":"10.3389\/fneur.2023.1137998","volume":"14","author":"O Corbali","year":"2023","unstructured":"Corbali O, Chitnis T. Pathophysiology of Myelin oligodendrocyte glycoprotein antibody disease. Front Neurol. 2023;14:1137998. https:\/\/doi.org\/10.3389\/fneur.2023.1137998.","journal-title":"Front Neurol"},{"key":"4710_CR15","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1038\/s41433-024-03108-y","volume":"38","author":"N Jeyakumar","year":"2024","unstructured":"Jeyakumar N, Lerch M, Dale RC, et al. MOG antibody-associated optic neuritis. Eye. 2024;38:2289\u2013301. https:\/\/doi.org\/10.1038\/s41433-024-03108-y.","journal-title":"Eye"},{"issue":"5","key":"4710_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1212\/CON.0000000000000768","volume":"25","author":"JL Bennett","year":"2019","unstructured":"Bennett JL. Optic neuritis. Continuum (Minneap Minn). 2019;25(5):1236\u201364. https:\/\/doi.org\/10.1212\/CON.0000000000000768.","journal-title":"Continuum (Minneap Minn)"},{"key":"4710_CR17","doi-asserted-by":"publisher","first-page":"1071115","DOI":"10.3389\/fmed.2022.1071115","volume":"9","author":"BE Ostrov","year":"2023","unstructured":"Ostrov BE. Reliability and reproducibility of antinuclear antibody testing in pediatric rheumatology practice. Front Med. 2023;9:1071115. https:\/\/doi.org\/10.3389\/fmed.2022.1071115.","journal-title":"Front Med"},{"key":"4710_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1546-0096-8-27","volume":"8","author":"PN Malleson","year":"2010","unstructured":"Malleson PN, Mackinnon MJ, Sailer-Hoeck M, et al. Review for the generalist: the antinuclear antibody test in children - When to use it and what to do with a positive titer. Pediatr Rheumatol. 2010;8:27. https:\/\/doi.org\/10.1186\/1546-0096-8-27.","journal-title":"Pediatr Rheumatol"},{"key":"4710_CR19","doi-asserted-by":"publisher","unstructured":"Molazadeh N, Bose G, Lotan I, Levy M. Autoimmune diseases and cancers overlapping with Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review. Multiple Scler J - Experimental Translational Clin. 2022;8(4). https:\/\/doi.org\/10.1177\/20552173221128170.","DOI":"10.1177\/20552173221128170"},{"key":"4710_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/ncn3.12790","volume":"12","author":"C Porey","year":"2024","unstructured":"Porey C, Jaiswal BK. Systemic association of Myelin oligodendrocyte glycoprotein antibody disease: A systematic review of literature. Neurol Clin Neurosci. 2024;12:71\u20139. https:\/\/doi.org\/10.1111\/ncn3.12790.","journal-title":"Neurol Clin Neurosci"},{"issue":"10","key":"4710_CR21","doi-asserted-by":"publisher","first-page":"e182928","DOI":"10.1001\/jamaophthalmol.2018.2928","volume":"136","author":"AR Lee","year":"2018","unstructured":"Lee AR, El-Dairi MA. Anti-myelin oligodendrocyte glycoprotein optic neuritis or neuroretinitis? JAMA Ophthalmol. 2018;136(10):e182928. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.2928.","journal-title":"JAMA Ophthalmol"},{"key":"4710_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12974-021-02160-9","volume":"18","author":"J Havla","year":"2021","unstructured":"Havla J, Pakeerathan T, Schwake C, et al. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well? J Neuroinflamm. 2021;18:121. https:\/\/doi.org\/10.1186\/s12974-021-02160-9.","journal-title":"J Neuroinflamm"},{"key":"4710_CR23","doi-asserted-by":"publisher","first-page":"953993","DOI":"10.3389\/fimmu.2022.953993","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Kong L, Zhao Z, et al. Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis. Front Immunol. 2022;13:953993. https:\/\/doi.org\/10.3389\/fimmu.2022.953993.","journal-title":"Front Immunol"},{"issue":"8","key":"4710_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11940-019-0579-9","volume":"21","author":"AM Fairbanks","year":"2019","unstructured":"Fairbanks AM, Starr MR, Chen JJ, Bhatti MT. Treatment strategies for neuroretinitis: current options and emerging therapies. Curr Treat Options Neurol. 2019;21(8):36. https:\/\/doi.org\/10.1007\/s11940-019-0579-9.","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"4710_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/cen3.12771","volume":"15","author":"T Misu","year":"2024","unstructured":"Misu T, Matsumoto Y, Kaneko K, Takahashi T, Takai Y, Ono H, et al. Myelin oligodendrocyte glycoprotein antibody-associated disorders: an overview. Clin Experimental Neuroimmunol. 2024;15(1):6\u201315. https:\/\/doi.org\/10.1111\/cen3.12771.","journal-title":"Clin Experimental Neuroimmunol"},{"key":"4710_CR26","doi-asserted-by":"publisher","first-page":"103216","DOI":"10.1016\/j.msard.2021.103216","volume":"56","author":"BK da Costa","year":"2021","unstructured":"da Costa BK, Banwell BL, Sato DK. Treatment of MOG-IgG-associated disease in paediatric patients: A systematic review. Multiple Scler Relat Disorders. 2021;56:103216. https:\/\/doi.org\/10.1016\/j.msard.2021.103216.","journal-title":"Multiple Scler Relat Disorders"},{"issue":"12","key":"4710_CR27","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s00415-020-10026-y","volume":"267","author":"DH Whittam","year":"2020","unstructured":"Whittam DH, Karthikeayan V, Gibbons E, Messina S, Molloy A, Hacohen Y, et al. Treatment of MOG antibody-associated disorders: results of an international survey. J Neurol. 2020;267(12):3565\u201377. https:\/\/doi.org\/10.1007\/s00415-020-10026-y.","journal-title":"J Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04710-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:30:07Z","timestamp":1773397807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04710-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4710"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04710-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to institutional and national regulations for single-patient case reports, formal ethics committee approval was not required. Written informed consent to participate was obtained from the patient\u2019s legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical details and images was obtained from the patient\u2019s legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}